The U.S. Food and Drug Administration (FDA) has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet
Category: Renal function
Fatty liver can damage other organs
Nonalcoholic fatty liver disease NAFL increases the risk of chronic liver diseases such as liver cirrhosis, liver cancer, type 2
